Skip to main content
. 2020 Apr 19;15:84. doi: 10.1186/s13014-020-01532-4

Table 3.

Changes of quality of life for 104 NPC patients treated by IMRT or VMAT with completions of all questionnaires at the four time points

All ti1 ti2 ti3 ti4 p-value
EORTC QLQ-C30
 Global quality of Life 53†‡§ 34¶※ 56# 67 < 0.01
 Physical functioning 92†‡ 81¶※ 88 92 < 0.01
 Role functioning 92†‡ 70¶※ 88 93 < 0.01
 Emotional functioning 79†‡ 72¶※ 85 85 < 0.01
 Cognitive functioning 85 77¶※ 85 85 < 0.01
 Social functioning 75†§ 66¶※ 77# 87 < 0.01
 Fatigue 21†‡ 46¶※ 29# 18 < 0.01
 Nausea and vomiting 8 42¶※ 12 7 < 0.01
 Pain 16 39¶※ 15 13 < 0.01
 Dyspnea 8 11 8 6 NS
 Insomnia 26 32¶※ 21 22 < 0.01
 Appetite loss 14†‡ 62¶※ 28# 13 < 0.01
 Constipation 12 27¶※ 18 17 < 0.01
 Diarrhea 11 12 10 8 NS
 Financial difficulties 21 22 22 18 NS
EORTC QLQ-HN35
 Pain 5†‡ 40¶※ 12 7 < 0.01
 Swallowing 5†‡§ 42¶※ 20 16 < 0.01
 Senses (taste/smell) 8†‡§ 51¶※ 29# 17 < 0.01
 Speech 6†‡§ 27¶※ 16 13 < 0.01
 Social eating 4†‡§ 48¶※ 22# 11 < 0.01
 Social contact 4†‡ 20¶※ 10 6 < 0.01
 Sexuality 13†‡§ 40¶※ 25 22 < 0.01
 Teeth 27 29 26 27 NS
 Opening mouth 4†‡§ 22¶※ 16 16 < 0.01
 Dry mouth 20†‡§ 62¶※ 54# 44 < 0.01
 Sticky saliva 16†‡§ 61¶※ 45# 34 < 0.01
 Coughing 18 22 18 19 NS
 Feeling ill 24 55¶※ 27 22 < 0.01

Analysis by multivariate ANOVA for repeated measures; IMRT Intensity modulated radiotherapy, VMAT Volumetric modulated arc therapy; ti1: before RT; ti2: RT 42.4 Gy; ti3: 3 months after RT; ti4: 12 months after RT; †: p < 0.05, ti1 vs. ti2; ‡: p < 0.05, ti1 vs. ti3; §: p < 0.05, ti1 vs. ti4; ¶: p < 0.05, ti2 vs. ti3; ※: p < 0.05, ti2 vs. ti4; #: p < 0.05, ti3 vs. ti4; NS: not statistically significant